SEC Tracker
Get the app

LENZ Therapeutics LENZ

LENZ Therapeutics, Inc. held its 2026 annual meeting of stockholders on June 12, 2026.

Form
8-K
Filed
Importance
Routine
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when LENZ Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. ImmunityBio IBRX public float $690M, Jun 30, 2025
  2. Anavex Life Sciences AVXL public float $708M, Mar 31, 2025, over 18 months old
  3. Immunome IMNM public float $729M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025